US EditionWHO releases first reports on shortages in fungal disease treatments and diagnostics
- On April 2, 2025, the World Health Organization published reports on fungal diseases.
- Fungal diseases are an increasing public health concern with growing resistance to treatment.
- The reports highlight the critical lack of effective medicines and diagnostic tools, especially in LMICs.
- Mortality for critical fungal infections reaches 88%; only four new drugs gained approval in the last decade.
- WHO calls for more investment in research, global surveillance, and financial incentives to combat these deadly infections.
23 Articles
23 Articles
Use of antifungals in agriculture may increase resistance in an infectious yeast, study suggests
Genomic changes in the infectious yeast Candida tropicalis may play a role in its resistance to antifungals, according to a new study. These genomic changes can be brought on by a common antifungal, TBZ. The study demonstrates that the use of TBZ in agriculture may contribute to the increasing problem of antifungal resistance.
Conservation newsecotopical.comNearly one-third of fungi on IUCN Red List are threatened with extinction
The International Union for Conservation of Nature (IUCN) recently updated its Red List of Threatened Species to include an additional 482 fungi, bringing the total to roughly 1,300 species of mushrooms, puffballs and other fungi. More than 400 of the species assessed are at risk of extinction, primarily threatened by agricultural expansion, deforestation and climate change, according to the IUCN’s latest update. Some 279 fungi species face exti…
WHO releases first reports on shortages in fungal disease treatments and diagnostics
The World Health Organization (WHO) today published its first-ever reports addressing the critical lack of medicines and diagnostic tools for invasive fungal diseases, showing the urgent need for innovative research and development (R&D) to close these gaps.
WHO sounds alarm over lack of tools to combat fungal infections
In the last decade, only four new drugs have been approved; in the next, only three are expected; current diagnoses do not meet the reality of all countries; the deadliest fungal pathogens have a lethality of up to 88%.
ObservadorIOL PortugalWHO warns that new drugs are needed for invasive fungal diseases
The alert is contained in two WHO reports that conclude that “doctors still face significant challenges”. Invasive diseases include meningoencephalitis and pulmonary cryptococcosis, among others.
Africa: WHO Issues Its First-Ever Reports On Tests and Treatments For Fungal Infections
Press Release - The World Health Organization (WHO) today published its first-ever reports addressing the critical lack of medicines and diagnostic tools for invasive fungal diseases, showing the urgent need for innovative research and development (R&D) to close these gaps.
Coverage Details
Bias Distribution
- 57% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
